After discovering a lump at 48, Cindy was diagnosed with BRCA1-positive triple-negative breast cancer. Through aggressive chemotherapy, a double mastectomy, and enrolling in a clinical trial, she remains in remission—crediting her recovery to genetic insights, advanced treatments, and an unwavering support system.
Confronting Triple-Negative Breast Cancer: A Story of Hope and Resilience Read More »
A 38-year-old lawyer and mother of two discovered a small breast lump while tandem nursing, only to learn she had stage 4 metastatic breast cancer. Five years later, she continues treatment, advocates for patient rights, and inspires others with her message of empowerment.
Forging Strength: A Mother’s Ongoing Battle with Breast Cancer Read More »
Diagnosed with breast cancer over 20 years ago, Tracy discovered it had metastasized while pregnant with her second child. Now a 21-year thriver, 18 with metastatic disease, she credits specialized support groups, family resilience, and evolving goals for sustaining her hope.
21 Years of Advanced Breast Cancer: Lessons in Hope and Resilience Read More »
April’s first diagnosis came in 2015 when a routine mammogram revealed a suspicious spot. Stage 1 breast cancer soon became her reality. Devastatingly, later April’s cancer had spread beyond her breast and lymph nodes, classifying it as metastatic breast cancer.
From Early Detection to Metastatic: An Ongoing Breast Cancer Journey Read More »
Diagnosed with triple-negative breast cancer at 57, Jewel J. turned to MD Anderson for holistic treatment. Through chemotherapy, surgery, radiation, and integrative medicine support, she reached remission in under a year and now champions wellness and self-advocacy
A Journey With Triple-Negative Breast Cancer Read More »
Stage IV NSCLC survivor Melissa C. has outlasted dire predictions through genetic testing, clinical trials, and a steadfast commitment to advocacy. Her journey proves that targeted therapies and a positive mindset can transform the fight against advanced lung cancer.
An Ongoing Triumph Over Stage IV Lung Cancer Read More »
After a shocking stage IV lung cancer diagnosis at age 65, Wells W. used his scientific background to pursue innovative treatments, including EGFR-targeted therapy. Now 91, he champions lung cancer research and patient advocacy through GO2 for Lung Cancer.
A Legacy of Hope: How a Stage IV Lung Cancer Diagnosis Led to New Frontiers in Research Read More »
Frank, a 56-year-old personal trainer, was shocked to learn he had stage 4 lung cancer. Genetic testing revealed an EGFR mutation, and targeted therapy quickly turned his life around. Now he’s sharing his inspiring “WIN the Day” mindset to motivate others
Advanced Lung Cancer: The Power of Winning Each Day Read More »
A 41-year-old retired firefighter and combat veteran went from stage IV lung cancer to no evidence of disease in just six months, thanks to ALK-targeted therapy and surgery at MD Anderson. Today, he’s back to training for IRONMAN and enjoying life with his family.
From Stage IV Lung Cancer to Cancer-Free: A Remarkable Recovery Read More »
Stage 4 lung cancer patient Sara Whitlock was given just a 3% chance of surviving five years. Thanks to targeted therapy through a clinical trial, she has no signs of disease nearly a decade later, illustrating the power of personalized treatments in extending both life and hope.
Nine Years Beyond a 3% Survival Chance of Stage IV NSCLC Read More »
